GCT President, Dr. Jeffrey Apter at AAIC’19

GCT President, Dr. Apter is currently attending the annual Alzheimer’s Association International Conference.

The event takes place in Los Angeles 14-18 of July. AAIC is devoted to sharing knowledge and discussing the progress in dementia science, including the latest advances in prevention, diagnosis and treatment of Alzheimer’s disease. The conference also provides its attendees with great networking opportunities among the top professionals in the CNS field.

If you would like to schedule a meeting with Dr. Apter, please contact us at bd@gctrials.com.

 

Updated: July 15, 2019

Permanent link: https://2022.gctrials.com/posts/dr-apter-at-aaic19/

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.